FDA Commissioner raises concern over sale of CBD services and products
Outgoing U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb expressed concern concerning the country’s leading drugstore chains attempting to sell CBD items.
Walgreens has recently established which they shall start selling CBD-infused sprays, ointments, balms, and spots in around 1,500 shops throughout nine states where medical cannabis is currently legal. Rival drugstore CVS Pharmacy, meanwhile, has introduced CBD topicals in around 800 shops across eight states.
During a House Appropriations Committee hearing on Gottlieb wednesday raised concern about Walgreens and CVS stepping in to the cannabis market.
Worldwide CBD Exchange
“So you see big-box stores wanting to promote CBD products for many uses where in actuality the claims appear to be potentially throughout the line, to treat discomfort, as an example,” he said.
FDA sets May 31 general public hearing on legalization of CBD in meals, beverages
An additional associated news, the agency has set the very first general public hearing regarding the legalization of CBD in meals and products for might 31, 2019. Continue reading